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ABSTRACT
The paired-end ditagging (PET) technique has been
shown to be efficient and accurate for large-scale
transcriptome and genome analysis. However, as
with other DNA tag-based sequencing strategies, it
is constrained by the current efficiency of Sanger
technology. A recently developed multiplex sequen-
cing method (454-sequencing
TM) using picolitre-
scale reactions has achieved a remarkable advance
in efficiency, but suffers from short-read lengths,
and a lack of paired-end information. To further
enhance the efficiency of PET analysis and at
the same time overcome the drawbacks of the
new sequencing method, we coupled multiplex
sequencing with paired-end ditagging (MS-PET)
using modified PET procedures to simultaneously
sequence 200000 to 300000 dimerized PET (diPET)
templates, with an output of nearly half-a-million
PET sequences in a single 4 h machine run. We
demonstrate the utility and robustness of MS-PET
by analyzing the transcriptome of human breast
carcinoma cells, and by mapping p53 binding sites
in the genome of human colorectal carcinoma cells.
This combined sequencing strategy achieved an
approximate 100-fold efficiency increase over the
current standard for PET analysis, and furthermore
enables the short-read-length multiplex sequencing
procedure to acquire paired-end information from
large DNA fragments.
INTRODUCTION
A major challenge facing us in this post-genomic era is how
to extract maximum information from completed genome
sequence assemblies (1), so as to address basic questions in
gene annotation, expression proﬁling, gene regulation and
genome variation.
The sequencing approach has clear advantages over
microarrays by elucidating the exact nucleotide content of
target DNA sequences. However, a major constraint has
been its higher cost and lower data-generation speed relative
to microarrays. As an improvement on methods involving one
template per read, serial analysis of gene expression (SAGE)
was developed (2,3). This strategy utilizes short DNA tags
representing an entire DNA fragment, and the concatenation
of these tags for efﬁcient sequencing enables the characteri-
zation of whole transcriptomes and genomes. However, the
mapping of short single tags to the genome often results in
positional ambiguities. This drawback was partially
addressed in recent modiﬁcations that speciﬁcally extracted
50 terminal signatures of cDNA (4,5), but it was the simul-
taneous tagging of both 50 and 30 terminal signatures that
provided an ideal solution. To achieve this, we initially
developed an intermediate approach that separately extracted
50 and 30 terminal tags from cDNA fragments for sequencing
(6). Subsequently, we developed gene identiﬁcation signature
(GIS) analysis, in which the 50 and 30 signatures of each
full-length transcript were simultaneously extracted, then
covalently-linked into paired-end ditag (PET) structures for
concatenated high-throughput sequencing and the accurate
demarcation of transcriptional unit boundaries in assembled
genome sequences (7). An average capillary sequencing
read (700–800 bp) of a single GIS-PET library clone would
reveal 10–15 PET U, thus representing a 20- to 30-fold
increase in annotation efﬁciency compared to the bidirec-
tional sequencing analysis of full-length cDNA (ﬂcDNA)
clones.
We have also successfully applied this PET-based DNA
analysis strategy to characterize genomic DNA fragments
enriched for speciﬁc target sites by chromatin immunopreci-
pitation (ChIP), and these chromatin immunoprecipitation-
PET (ChIP-PET) analyses have provided a global overview
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(6), as well as Oct4 and Nanog targets in the mouse
genome (8).
The PET concept can conceivably be applied to other DNA
sequence analyses that will beneﬁt from paired-end
characterization, including the study of epigenetic elements
and genome scaffolding. One point to note is that while
the number of sequencing reads ( 50000) required for a
comprehensive GIS-PET or ChIP-PET analysis is miniscule
for most genome centers with state-of-the-art Sanger capil-
lary sequencers, and within the reach of core facilities in
university laboratories, the ﬁnal cost of each PET experiment
can be signiﬁcant. Hence, we are continually seeking ways
to improve the efﬁciency and cost-effectiveness of PET
analysis.
Recently, a novel, highly-parallel multiplex sequencing-
by-synthesis method based on pyrosequencing in picolitre-
scale reactions (454-sequencing ) was reported, in which
 300000 DNA templates were simultaneously sequenced
in a single 4 h machine run to a read-length of  100 bases,
with an accuracy of 99.6% (9). Although this multiplex
sequencing approach, as described, potentially yields a
remarkable 100-fold increase in throughput compared with
current Sanger capillary sequencing technology, its obvious
weaknesses are the short-read length that limits wider
application to many genome sequencing projects, and its
inability to obtain paired-end information.
Another recent advance is the Polony sequencing
technology (10) that has as its chief advantages low seq-
uencing cost, and the ability to produce paired-end reads
of DNA fragments at a raw data acquisition rate report-
edly an order of magnitude faster than conventional Sanger
sequencing. In its current manifestation, however, the
technology suffers from a lower-than-predicted through-
put ( 140 bp/s) and raw base-calling accuracies poorer
than in Sanger sequencing. In addition, an unusual
sequencing-by-ligation scheme results in short, discon-
tiguous paired-end tags (each of 13 bases interrupted by an
indeterminate gap of 4 to 5 bases) that is insufﬁcient for
speciﬁc mapping in complex genomes, thus precluding the
Polony method from applications involving mammalian
genome sequencing.
It was apparent to us that a melding of technologies would
be highly beneﬁcial: the massively-parallel, short-read nature
of the new 454-sequencing method lends itself well to
enhanced PET analysis: each  40 bp PET would compensate
for the inherent disadvantages of short-reads by providing
paired-end information from long contiguous DNA frag-
ments. Mapping of these PETs to assembled genomes
would allow the original sequence to be inferred. Further-
more, by a simple modiﬁcation of the original GIS-PET
procedure, we were able to easily dimerize PETs prior
to multiplex sequencing, thereby further increasing data-
gathering efﬁciency. Finally, the very high sequencing
throughput of 454-sequencing should allow the global ana-
lysis of transcriptomes and genomes at an unprecedented
speed.
In this report we describe the utility, efﬁciency and accur-
acy of applying this multiplex sequencing of paired-end
ditags (MS-PET) analysis to characterize both the human
transcriptome and genome.
MATERIALS AND METHODS
Cell lines and drug treatment
MCF7 human breast carcinoma cells were obtained from
ATCC and veriﬁed to be positive for estrogen receptor
expression. They were cultured in DMEM media supplemen-
ted with 10% fetal calf serum (FCS), up to passage number 3.
The cells were serum-starved for 24 h prior to treatment with
10 nM beta-estradiol for 12 h, then harvested by centrifuga-
tion and washed with phosphate-buffered saline (PBS). For
the additional sample that was sequenced using the Sanger
method, untreated MCF7 cells were harvested as above at
log phase growth.
HCT116 human colorectal carcinoma cells (a gift from
Dr B. Vogelstein, Johns Hopkins University) were cultured
in DMEM with 10% FCS. The cells were treated with
0.1 M 5-Fluorouracil for 10 min to activate p53 and induce
target gene expression.
GIS-PET analysis on MCF7 cells
Cells were lysed in Trizol, and the RNA subsequently extrac-
ted was subjected to GIS-PET analysis essentially as
described previously (7), except for the use of a modiﬁed
cloning vector pGIS4a (Supplementary Figure 1; vector and
sequence available on request). Brieﬂy, ﬂcDNA was prepared
by the CapTrapper method (11), and inserted into pGIS4a
after the excision of the poly(A) tail with GsuI. This obviates
the need for a 30 adapter-ligation step. Plasmid maxiprep
prepared from the ﬂcDNA library was digested with MmeI
to excise all of the inserted ﬂcDNA except for the terminal
20 bp signatures. After end-polishing and plasmid recircular-
ization, the recircularized plasmids (each now containing a
single-PET of  36 bp) were transformed into bacteria to
give the GIS single-PET library. A maxiprep of this single-
PET library was digested sequentially with BseRI and
BamHI to release PETs containing a single BamHI cohesive
site. PETs were gel-puriﬁed, and ligated to form dimerized
PETs (diPETs) of  80 bp size. These diPETs were again
gel-puriﬁed, and subjected to multiplex sequencing (9)
using a GS20 sequencer (Roche).
ChIP-PET
ChIP assays with HCT116 cells were carried out as described
previously (6). Brieﬂy, cells were treated with 1% formalde-
hyde for 10 min at room temperature to crosslink proteins and
DNA. Formaldehyde was inactivated by addition of 125 mM
glycine, and the crosslinked cells were lysed and sonicated.
Chromatin extracts containing gDNA fragments of average
size  500 bp were immuno-precipitated using anti-p53
DO1 monoclonal antibody (Santa Cruz).
ChIP-enriched gDNA fragments were de-linked, size-
fractionated on columns to remove excessively small frag-
ments (Invitrogen), blunted using the end-it kit (Epicentre),
cloned into pGIS3h (Supplementary Figure 2; vector and
sequence available on request) and transformed into TOP10
Escherichia coli (Invitrogen) to give the ChIP DNA library.
Similar to the standard GIS procedure, plasmid DNA
prepared from the ChIP DNA library was digested with
MmeI, end-polished, recircularized and transformed into
bacteria to give the GIS single-PET library. Plasmid DNA
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BseRI, then alkaline phosphatase-treated to inactivate the
resulting cohesive site, and ﬁnally BamHI-treated to liberate
single-PETs. Puriﬁed single-PETs were dimerized to form
 88 bp diPETs and subjected to multiplex sequencing
using a GS20 sequencer.
Data collection and analysis-transcriptome analysis of
MCF7 cells (library SHC015)
For both the transcriptome analysis of MCF7 cells, and the
ChIP-PET analysis of HCT116 cells, PETs were extracted
from raw sequences using the PET Tool software designed
in-house (K. P. Chiu, C.-H. Wong, Q. Chen, P. Ariyaratne,
H. S. Ooi, C.-L. Wei, W.-K. Sung and Y. Ruan, manuscript
submitted) and mapped to the human genome assembly
(build hg17; http://genome.ucsc.edu). Details of the PET
extraction and mapping procedure are found in (7). Details
of p53 motif identiﬁcation are in (6).
Novel gene discovery/gene prediction validation
by PCR
Primary PCR was performed using primers that were
designed based on PET sequences (sequences available on
request). Primer sequences were adjusted to optimize pre-
dicted annealing temperatures (based on nearest-neighbor
calculations) by incorporating ﬂanking vector sequences as
required. Ampliﬁcation was performed using Qiagen
HotStarTaq as per the manufacturer’s protocols, for 25 cycles,
at an annealing temperature of 55 C. For each reaction, 4 ng
of DNA from the ﬂcDNA library was used as template. A
total of 5 ml of each 25 ml reaction was visualized on a 1%
agarose gel. A total of 5 ml of each primary PCR was then
used as template for secondary PCR. For these secondary
PCR, primers were designed using Primer3 (12) at http://
frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi, based
on the genomic DNA sequences spanned by each PET. For
convenience, wherever possible secondary PCR products
were designed to be  400–500 bp in size. The GenScan
algorithm (13) at http://genes.mit.edu/GENSCAN.html was
used to predict exon locations, to minimize the chances of
inadvertently designing primers within introns.
Quantitative PET analysis by real-time RT–PCR
PCR primers (sequences available on request) were designed
using Primer3, based on the transcripts corresponding to each
of the 12 selected PETs. For real-time PCR analysis, 100 ng
of mRNA was reverse-transcribed using SuperScript II
(Invitrogen) in a ﬁnal volume of 20 ml, and 2 ml of this
reverse-transcribed mRNA was ampliﬁed in a LightCycler
(Roche) for 36 cycles using the FastStart DNA Master
SYBR Green I kit. Each PCR was performed in triplicate
and threshold cycle (Ct) values for each amplicon of interest
were normalized against that of Actin as a reference.
Data mining details
PET mapping to genome assembly. More details are found in
(7), but brieﬂy, PET sequences were extracted based on the
expected characteristic arrangement of bases in each diPET,
viz. (34–40 bp PET)-GTCGGATCCGAC-(34–40 bp PET).
Extracted PETs were mapped to the human genome assembly
using a Compressed Sufﬁx Array-derived algorithm that is
much faster than BLAST, while maintaining similar accuracy
(H. S. Ooi, Q. Chen, K. P. Chiu, C. K. Wong, T.-W. Lam,
C.-L. Wei, Y. Ruan and W.-K. Sung, manuscript submitted).
For transcript analysis, we mandated a minimum 16 base
contiguous match for the 50 signature and a minimum 14
base contiguous match for the 30 signature of each PET
when mapping to the genome; for ChIP analysis, we set a min-
imum 17 base contiguous match for both signatures. Moreover,
we required that the 50 signature not extend beyond position
19, and the 30 signature not start before position 18. Finally,
each 50 signature was matched with its cognate 30 signature
against existing genome sequence data, the criteria being that
both the 50 and 30 signatures must be present on the same
chromosome, be on the same strand, in the correct orientation
(50 to 30), and within a predeﬁned genomic distance (1 Mb for
transcripts, 4 kb for the ChIP-enriched gDNA fragments).
PETs that failed to meet these criteria were considered
‘unmappable’, and archived separately for additional analysis.
Clustering of mapped PETs into putative genes is based on
both 50 and 30 mapping distance: for transcriptome analysis
purposes, within a cluster either of the two ends should be
within 1 kb of other members in the same cluster. For
ChIP-PET analysis, as long as the PETs overlap with any
member we include them in the same cluster.
Mapping accuracy analysis. Based on the counts of single-
locus PETs mapped to data in any of the RefSeq, Known-
Gene, GenBank mRNA or MGC sub-bases (representing
known genes) within the UCSC database, PETs in the top
20 most abundant clusters were selected and the mapping
of the 50 and 30 signatures against documented termini was
examined. Mapping accuracy was determined by arbitrarily
setting a 50 bp cutoff. This procedure was subsequently
extended to the larger set of all mapped single-locus PETs
that corresponded to known genes in the UCSC database.
Gene categorization. Mapping statistics of each PET was
downloaded from the T2G browser (http://t2g.bii.a-star.edu.sg)
mentioned previously (7), and sorted into various categories
using databasing software based on the following deﬁnitions:
(i) known gene: PET sequence maps in the vicinity of data
in any of the sub-bases RefSeq, KnownGene, MGC or
GenBank mRNA; if both signatures map within ±50 bp of
both termini, the match is deemed ‘accurate’, otherwise it is con-
sidered a splice variant with an alternative TSS and/or PAS; (ii)
novel: within the PET span, there is no existing information in
any database category; (iii) gene prediction: there is existing
information within any of the Ensembl EST, Twinscan, Genscan
or SGP Gene databases (overlapping data in any of the other
databases will take precedence over gene predictions); (iv)
ESTs: there is existing information in only the EST sub-base
(overlapping data in any of the known gene sub-bases takes
precedence); (v) putative bidirectional promoter regulated: two
genes directly adjacent to each other are expressed in opposite
directions, originating from an intergenic region not >1k bi n
length; (vi) antisense genes: PETs were ﬁrst sorted into positive
strand and negative strand mappings, and clustered by location
to indicate putative genes. Overlapping (either complete or
partial) of gene clusters from opposite mapped orientations
indicates putative antisense genes.
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recovery of initially-unmapped PETs to those that could
be subsequently mapped after allowing a single-base
insertion (of the same base) or deletion within only homo-
polymer regions (deﬁned as stretches of two or more
identical bases) in the PET sequence. This restriction was
imposed to reduce mapping artifacts (noise) caused by
allowing insertions/deletions anywhere within the PETs.
Within the recovery pipeline, a single-base deletion was
permitted within the entire set of unmapped PETs, which
were subsequently remapped to the genome; only PETs that
now mapped to single loci were retained: these would be
considered the result of apparent base over-calling. The
remaining PETs were permitted a single-base insertion,
remapped, and again only those that could be mapped to
single loci were retained: these PETs would be considered
the result of base under-calling. All remaining ditags were
considered ‘unmappable’. Validation of the approach was
performed by determining the fraction of recovered PETs
that mapped within 200 bp of known gene annotations in
the UCSC database.
RESULTS
Preparation of diPETs for multiplex sequencing
We constructed an ﬂcDNA library from estradiol-treated
MCF7 cells, which is believed to be a useful in vitro model
for estrogen-responsive breast cancer (14), following a
procedure essentially identical to our published GIS analysis
protocol (7) with minor modiﬁcations to the cloning vector
(pGIS4a; Supplementary Figure 1). Subsequently, the
plasmid clones of this ﬂcDNA library were subjected to
Mme1 digestion, followed by plasmid self-ligation to form
a single-PET library, in which each plasmid contained a
single-PET ﬂanked by a BamH1 site on its 50 side and a
BseR1 sites on its 30 side (Figure 1). BseRI digestion would
then release the 30 end of the insert with an AA dinucleotide
overhang, and subsequent BamHI digestion would excise a
43 bp asymmetric PET with only one compatible cohesive
site (BamHI) at the insert 50 terminus. Ligation of single-
PETs resulted in their dimerization into  80 bp diPETs.
The collection of diPETs was then subjected to multiplex
sequencing analysis (Figure 1) using a GS20 sequencer.
From a single GS20 machine run of a full picotiter plate, a
total of 462 626 PET units were generated, which were col-
lapsed into 313 983 unique PET sequences (Supplementary
Table 1).
Similarly, we tested the use of the MS-PET sequencing
strategy for enhanced ChIP-PET analysis. From the original
ChIP DNA used for whole-genome mapping of putative
p53 binding sites in HCT116 human colon cancer cells (6),
we constructed a p53 ChIP DNA library in an improved
vector (pGIS3h; Supplementary Figure 2) and converted
this library into  88 bp diPET templates for MS-PET
analysis. A partial (1/16) picotiter plate run generated
23 283 PET units, which were collapsed into 22 687 unique
p53 ChIP-PET sequences for further analysis.
Figure 1. Schematic overview of the MS-PET sequencing strategy. (A) The outline procedure showing the construction of diPETs, which were subjected to
multiplex sequencing. (B) Structural details of a diPET. The numbers 5 and 3 represent bases within the 50 and 30 signatures, respectively, in each PET
component. The orientations of cDNAs are indicated by the ‘AA’ remaining after poly(A) tail removal.
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High-quality PET sequences derived from the GIS-PET lib-
rary were mapped to the human genome sequence assembly
build hg17 (http://genome.ucsc.edu). Based on the same
empirically-determined criteria used in GIS analysis for
mapping PETs to genome (7), viz. 50 and 30 signatures
must contain minimum contiguous 16 and 14 bp matches,
respectively, to the genome; they must be in the correct
orientation (50 to 30); and within an arbitrary genomic span
of one million base pair, we found that of the 313 983 unique
PET sequences, 157 697 (50.22%) could be mapped on the
ﬁrst-pass to hg17 (Table 1). The 50 signatures displayed con-
tiguous matches to the genome ranging from 16 to 19 bases,
with a modal match of 18 bases, while the 30 signatures
displayed matches from 14 to 21 bases, with a modal
match of 16 bases.
It is noteworthy that 156286 PET sequences (49.78%)
remained unmapped to the genome under standard ﬁrst-pass
mapping criteria (Table 1). Although we had expected that
a portion of the PETs would remain unmapped for reasons
including gaps within the genome assembly, sequence
mismatches due to polymorphisms, genome variations in
cultured cell lines, and sequencing error, the percentage of
unmapped PETs from this library was considerably higher
than the range of 20–30% that we consistently ﬁnd in
GIS-PET libraries sequenced by the standard Sanger capillary
method [(7) and P. Ng, unpublished data].
To speciﬁcally determine what portion of the unmapped
PETs in this library was attributable to the unique sequencing
characteristics of the multiplex sequencing method, we
compared PET sequences generated from the same cell line
(MCF7) but using Sanger capillary sequencing (Supplement-
ary Table 2). From 135757 PET sequences generated
by capillary sequencing, 102660 (75.62%) were mapped
to the human reference genome sequence, and the rest
(33097; 24.38%) were unmappable. Therefore, the non-
mapping rate of PET sequences by MS-PET analysis was
about 25.40% (49.78–24.38%) higher than that of PET
sequences generated by the Sanger capillary method, suggest-
ing that about 25% of the 313983 PETs generated in this MS-
PET experiment were probably miscalled by the multiplex
sequencing method.
It was previously reported that the GS20 multiplex sequen-
cing is susceptible to base mis-calling (over-call or under-
call) within homopolymeric regions (deﬁned as an occurrence
within any sequence of two or more identical adjacent bases)
(9). We examined the extent to which this phenomenon might
affect our analysis. By allowing a sequential one-base
removal and addition (but not a substitution) of the same nuc-
leotide base to counteract the possible base over- or under-
calling within only homopolymer stretches in the ‘unmapped’
156286 PET sequences, we were able to identify apparent
1 base homopolymeric errors (Supplementary Figure 3) and
recover 56 194 PETs that could be mapped speciﬁcally to a
single-locus in the human genome. This resulted in only
100092 (31.88% of 313983) PET sequences that remained
unmapped, or a total of 213891 (68.12% of 313983) mapped
PET sequences (Table 1). Because we allowed only single-
base errors in this analysis for stringency, the number of
recoverable PETs is most likely underestimated. It is apparent
therefore that with the correction of such homopolymeric
errors, the sequencing accuracy of multiplex sequencing is
comparable to the Sanger capillary method, suggesting that
homopolymer base-calling errors were indeed a major con-
tributing factor towards the initially higher mapping failure
rate of MS-PET sequences, and that mapping algorithms for
MS-PET- derived data should take this into consideration.
Detailed examination of the error-distribution across dif-
ferent homopolymer lengths (Supplementary Data) showed
that these were consistent with earlier published observa-
tions that total sequencing errors within homopolymer
stretches increased with homopolymer length (Supplementary
Figure 4). In addition, the percentage of sequenced bases
from long homopolymer stretches within the 56194
recovered PETs was higher, compared to bases from homo-
polymer stretches of the same length within the 136612
single-locus PETs that were mapped on the ﬁrst-pass (Supple-
mentary Table 3). This is not surprising, given the increased
occurrence of sequencing errors with homopolymer length,
possibly coupled with decreased PET sequence complexity,
both factors contributing to decreased mapping ability.
Mapping of GIS-PET sequences to known human
transcription units
All 157697 PET sequences that mapped to the human
genome before homopolymer correction were subsequently
clustered into 22992 groups on the basis of similar (within
1 kb proximity to one another) 50 and 30 tag positions.
Analysis was performed on data prior to homopolymer
correction to increase stringency. These 22992 clusters may
therefore be taken to represent the transcriptome of estradiol-
treated MCF7 cells (Supplementary Table 1). A total of
20864 clusters comprising 136612 PETs (86.63% of all
mapped PETs) were located on unique chromosomal loci,
while the remaining 21085 mapped PETs were found in
Table 1. Mapping of PETs to the human genome
PETs Percentage
Total PETs in GIS-PET library
analyzed by MS-PET
313983 100.00%
Initial mapped PETs 157697 50.22%
PETs mapped to a single-locus 136612 86.63% (of
mapped PETs)
PETs mapped to multiple loci 21085 13.37% (of
mapped PETs)
Initial unmapped PETs 156286 49.78%








errors ( 1 base)
27047 8.61%
Final mapped PETs 213891 68.12%
PETs mapped to a single-locus 192806 90.14% (of
mapped PETs)
PETs mapped to multiple loci 21085 9.86% (of
mapped PETs)
Final unmapped PETs 100092 31.88%
aBecause the same PET sequence can contain both over-call (+1) and
under-call ( 1) errors, each category of recovered PETs is not mutually
exclusive. Thus, the total PETs recovered is not a simple summation. See
Supplementary Data for details on the error-distribution analysis performed.
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ment to expressed pseudogenes, duplicated genes, repetitive
regions and possibly non-speciﬁc mapping.
To determine if the PET sequences were accurately
mapped to known genes annotated in the human genome,
we focused ﬁrst on the top 20 most abundant PET clusters
(comprising 10387 individual PET sequences) that matched
to well-characterized known genes. As previously described
(7), these top 20 clusters would be expected to represent
abundant and well-studied genes (as distinct from an analysis
of all clusters in the library, which would be expected to
include tentative or less well-studied annotations), and should
therefore provide an accurate indication of the library quality
in terms of intact transcript sequences, and hence ditag
mapping accuracy. The vast majority of PETs in this class
(10083 of 10387, or 97.07%) were mapped at well-deﬁned
50 and 30 boundaries (both termini mapped simultaneously)
within an arbitrary ±50 bp of known transcripts (including
all documented transcript splice variants) of these genes.
This result showed that the library analyzed in this study
was of high-quality in terms of full-length transcript content,
and also that the MS-PET sequences were of high accuracy.
We then extended this analysis to all 125986 PETs (within
the set of 136612 single-locus PETs) that matched known
transcript information (viz. KnownGene, RefSeq, Human
mRNA and MGC in the UCSC genome browser), and
found that a total of 93325 (74.08%) PETs could be mapped
within 50 bp of known termini, with both tags matching,
respectively the 50 and 30 ends of documented termini
(Table 2). The remaining PETs therefore potentially represent
new transcripts of known genes with alternative 50 transcrip-
tion start sites or 30 polyadenylation sites. This percentage
was comparable to the results derived from capillary-
sequenced PETs of MCF7 cells (data not shown) and our
previous results of other samples (7).
To examine the quantitative nature of MS-PET analysis, an
arbitrary selection of 12 PETs with counts ranging from 6 to
3144 was used as the basis for designing PCR primers against
each corresponding transcript. Quantitative real-time PCR
performed on reverse-transcribed mRNA from the estradiol-
treated MCF7 cells indicated that yields of each PCR product
(relative to actin as an internal reference) followed a trend
that, in general, corresponded to PET counts, viz. PET counts
were inversely related to normalized Ct values (Figure 2).
This result indicated that the MS-PET method did not
excessively distort the relative representation of transcripts
within the cells. However, there were obvious outliers
(e.g. BRCA1, Figure 2), where poor correlation was observed
between the normalized Ct values and PET counts. This is to
be expected, as our study focused on PET counts derived only
from single-locus-mapped PETs, omitting possible gene
duplications (including expressed pseudogenes), which
would be expected to contribute to increased PCR yields.
Conversely, the presence of internal exon deletions or
rearrangements may result in anomalously low PCR yields
with certain primer pairs. Finally, there also exists the pos-
sibility that some distortion of transcript representation may
occur during the various cloning procedures. Nonetheless,
the general agreement between PET counts and transcript
representation suggests that MS-PET provides a useful
semi-quantitative measure of gene expression. The results
further indicate that transcripts with PET counts as low as




While the majority (15163 of 20860 single-locus gene
clusters) of MS-PET-deﬁned transcripts mapped to known
genes, a small but signiﬁcant portion (Table 3) represented
full-length transcripts previously deﬁned only by partial
EST sequences (3405 PET clusters), de novo predictions
(2202 PET clusters), or were mapped to regions devoid of
any transcript information, therefore identifying hitherto-
unknown genes (1476 PET clusters). Examples are shown
in Supplementary Figure 5.
To validate previously-uncharacterized transcripts identi-
ﬁed by MS-PET, we performed nested PCR on the original
ﬂcDNA library using primers that were designed from the
50 and 30 PET signatures and genomic DNA sequence
information, and conﬁrmed that 36/48 (75.0%) putative
novel genes and 41/48 (85.4%) of the predicted genes were
authentic. Sequencing of an arbitrary selection of 25 of
these amplicons veriﬁed 11/13 (84.62%) of PET-identiﬁed
novel genes, and 12/12 (100%) of PET-mapped predicted
genes. An example from each of these two categories is
shown in Figure 3.
One putative novel gene transcript was identiﬁed by a single
copy PET_ID 48955.1, with a genomic span of 8523 bp on
chromosome 4. The clone was subjected to full-length sequen-
cing analysis, whereupon it was revealed that this transcript is
1.2 kb long and contains 4 exons. This transcript is expressed
from a putative bidirectional promoter also regulating a known
gene transcript (FLJ20032). PET_ID 282423.1 and PET_ID
282424.1 identiﬁed a single exon gene of 427 bp, which had
previously been predicted by at least two independent compu-
tational prediction programs. Given its small size, lack of
intron/exon organization and location between two LINEs, it
may be a non-coding mobile DNA element.
Table 2. Mapping of PETs to known gene transcripts
Top 20 PET clusters Percentage % Known single-locus PETs Percentage %
Total PET sequences 10387 100.00 125986 100.00
Matched to known transcripts 10083 97.07 93325 74.08
Novel extended 50 termini 64 0.62 4742 3.76
Novel extended 30 termini 24 0.23 2956 2.35
Novel truncated 50 termini 36 0.35 3528 2.80
Novel truncated 30 termini 169 1.63 5543 4.40
Unclassified 11 0.11 15 892 12.61
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Of the 22687 unique p53 ChIP-PET sequences obtained,
10036 (44.24%) were mapped to the human genome
sequence using the primary mapping parameters, i.e. without
applying homopolymer error correction. Of these, 8896
(88.64%) PETs were mapped to single chromosomal loci.
In addition, a total of 1240 PET sequences that were non-
identical, but which nonetheless mapped to identical chromo-
somal locations with only a few (<5) base pair difference
were considered to be derived from the same ChIP DNA frag-
ments (details in Supplementary Data and Supplementary
Tables 4 and 5). The minor variation was considered a result
of artifacts arising from manipulations during molecular
cloning and sequencing. Of the 7656 PETs remaining, the
majority (7529 of 7656) were mapped as singletons along
the genome (i.e. only 1 PET per locus), while 127 PET-
deﬁned loci formed 57 discrete clusters, each comprising
2 to 6 PETs. As we had demonstrated in our previous study
(6), these PET overlap clusters represented regions enriched
by the ChIP procedure. Thus, the genomic loci mapped by
the 57 clusters were most likely p53 transcription factor
binding sites.
For validation purposes, we compared these 57 PET clus-
ters to the p53 binding sites identiﬁed in our previous p53
ChIP-PET analysis, which was capillary-sequenced. We
found that 55 of the 57 clusters (96.5%) matched. Further-
more, the majority of these (42 of 55; 76.36%) contained
complete p53 consensus binding motifs (Supplementary
Table 6), with an additional three regions containing p53
half-sites, when analyzed using optimized weighted matrices
p53 motif model, p53PET (6), or by the MatInspector algo-
rithm (15). The high correlation of PET clusters between
the two studies suggests that the MS-PET strategy is at
least as reliable as standard ChIP-PET experiments for the
global identiﬁcation of transcription factor binding sites.
In this limited MS-PET analysis of ChIP DNA, 127 PETs
forming 57 putative p53 binding sites were obtained, against
a background ‘noise’ of 7529 singletons. This gave a
signal-to-noise ratio of 127/7529 or 1.68%. This is consider-
ably lower than the similar ratio obtained from the larger
reference dataset (6), wherein 4302 PETs (in 1766 clusters)
were identiﬁed against a background of 61270 singletons,
4302/61270 ¼ 7.02%. It is likely that the greater sequence
coverage of the reference dataset contributes to the higher
Figure 2. Validation of MS-PET-identified transcripts by quantitative real-time RT–PCR. Columns represent Mean Ct values (normalized against that of Actin)
±SD of each of 11 amplicons (n ¼ 3). PET counts for each candidate transcript are shown in italics above each column. IFGBP (Interferon-gamma binding
protein); SFXN4 (sideroflexin 4); TRUB2 (TruB pseudouridine synthase homolog 2); AARS (alanyl-tRNA synthetase); BRCA1 (breast cancer 1, early onset);
PP5 (protein phosphatase 5, catalytic subunit); CBX3 (Chromobox protein homolog 3); SSR2 (signal sequence receptor); SET (SET translocation); CTSD
(cathepsin D lysosomal aspartyl peptidase); TFF1 (Trefoil factor 1); Actin (reference), PET counts ¼ 33.
Table 3. Categorization of transcripts identified by MS-PET sequencing
analysis
PET clusters PETs PET counts
Known genes 15163 125986 213026
ESTs 3405 5504 7020
Gene prediction 2202 3168 4093
Novel genes 1476 1954 2240
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the number of PET clusters that would be identiﬁed.
DISCUSSION
We have established an effective paired-end scheme for the
newly-developed short-read multiplex sequencing technology
(9), and thereby enabled the characterization of mammalian
transcriptomes and genomes using an ultra high-throughput,
high information-content, and low-cost sequencing system.
By making possible the extraction of paired-end informa-
tion from long DNA fragments, we were able to use MS-
PET to overcome the short-read obstacle of 454-sequencing
in its current format as the GS20 sequencer. We were also
able to further increase the analysis efﬁciency of the existing
PET approach (6,7), which is itself already an improvement
over conventional sequencing-based genome analysis.
A single 4 h run of one GS20 sequencer was previously
shown to produce more than 25 million bases of high-quality
sequence, with an average read-length of 110 bases (9). To
Figure 3. Examples of genes identified by MS-PET analysis. (A) Novel gene discovery. PET_ID# 48 955.1 (green arrowed line) identifies a novel gene transcript
on chromosome 4, and is verified by PCR [inset; F, flanking (primary); N, nested (secondary)] and DNA sequencing of the amplicon (black arrowed lines
A07FF and A07FR). (B) Validation of a predicted gene. PET_ID# 282 423.1 (green arrowed line) identifies a predicted gene on chromosome 4, and is verified by
PCR [inset; F, flanking (primary); N, nested (secondary)] and DNA sequencing of the amplicon (black arrowed blocks G06FF and G06FR).
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our existing PET procedures by dimerizing asymmetric
PETs into diPET templates, such that each MS-PET read
would reveal two PET sequences. This immediately doubled
the output of MS-PET analysis. As demonstrated in this
study, we were able to obtain a total of 462626 PETs from
a single 4 h MS-PET run. With further streamlining, we
can now generate over 600000 PETs from each MS-PET
run (C.-L. Wei, unpublished data).
For comparison purposes, in the same 4 h period, a
state-of-the-art Sanger 96-well capillary sequencer (ABI
3730 · l) on a rapid-run protocol can produce a total of
about 320000 bases (Phred score >20) from 640 templates
(data obtained from http://www.appliedbiosystems.com/
products/abi3730xlspecs.cfm), or about 6400 PETs (assuming
a best-case average of 10 PETs per clone, 500 bases/read
in the rapid-run protocol). MS-PET therefore represents a
further 100-fold improvement over PET analysis using
Sanger capillary sequencers. It is expected that the prototype
MS-PET sequencing methodology can be further improved
for increased efﬁciency and accuracy.
It is known that 454-sequencing is prone to base mis-
calling in homopolymer regions (9). While this poses a
potential issue for de novo genome sequencing, homopolymer
errors can be at least partly resolved in MS-PET analysis
because PET sequences obtained from MS-PET experiments
are mapped to reference genome sequences. As described in
this study, a prototype scheme for correcting over- and
under-call homopolymer errors in PET sequences by allowing
single-base deletions and insertions, respectively, was valid-
ated. The resulting mapping rate is comparable to that of
PETs generated by Sanger capillary sequencing.
The current reagent cost is US$5000 for generating
half-a-million PETs in a 4 h machine run of GS20 sequen-
cing. The ability to generate one million PET sequences in
a single working day for under US$10000 using MS-PET
contrasts with Sanger capillary sequencing, where it would
cost at least US$100000 (estimated US$1 per sequence
read of 500 bases per template, rapid-run, revealing 10
PETs; 100000 reads for one million PETs) and take months
to produce the same amount of information. This represents a
substantial advance in both cost-reduction and speed-
improvement for PET analysis.
The data presented in this work validates the feasibility of
using MS-PET for very high-efﬁciency and comprehensive
transcriptome analysis and whole-genome interrogation.
Using MS-PET to perform a comprehensive transcriptome
analysis, or whole-genome mapping of transcription factor
binding sites after ChIP enrichment, would require a single
4 h run at a current cost of  US$5000 (9), resulting in the
collection of half-a-million PET sequences. These represent
sufﬁcient transcripts for a useful proﬁle of the human tran-
scriptome, or of the global localization of transcription factor
binding sites in the human genome. The completeness of the
proﬁle would depend on the complexity of the system being
analyzed.
The PET concept, as exempliﬁed by GIS-PET for tran-
scriptome analysis (7) and ChIP-PET for whole-genome
transcription factor binding site mapping (6), can conceivably
be applied to other DNA fragment analyses where paired-end
sequence information would be useful. These may include the
identiﬁcation of epigenetic elements, mapping chromosomal
variations in cancer genomes, and assisting in genome
scaffolding. The recent rapid development of new sequencing
technologies that are ever faster and cheaper promises to
revolutionize the ﬁeld of genome characterization (16,17).
The MS-PET procedure presented here, as well as optimi-
zations in future versions that continue to exploit expected
improvements in sequencing read-lengths or throughput,
should prove to be of considerable utility in this arena.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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